$STAA
STAAR Surgical Co Stock $staa

$staa Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000114420416100926 Filed on May 11, 2016

Income Statement

Concept	2016 Q2	2015 Q2
Revenue	$19.27M	$18.86M
YoY Change	2.18%	-6.54%
Cost Of Revenue	$6.276M	$5.960M
YoY Change	5.3%	-5.31%
Gross Profit	$12.99M	$12.90M
YoY Change	0.73%	-7.09%
Gross Profit Margin	67.43%	68.4%
Selling, General & Admin	$16.14M	$10.78M
YoY Change	49.72%	-6.54%
% of Gross Profit	124.22%	83.57%
Research & Development	$6.906M	$3.580M
YoY Change	92.91%	2.76%
% of Gross Profit	53.15%	27.75%
Depreciation & Amortization	$591.0K	$497.0K
YoY Change	18.91%	9.71%
% of Gross Profit	4.55%	3.85%
Operating Expenses	$23.05M	$14.41M
YoY Change	59.93%	-4.05%
Operating Profit	-$10.05M	-$1.511M
YoY Change	565.32%	12.59%
Interest Expense	$28.00K	-$930.0K
YoY Change	-103.01%	-2918.18%
% of Operating Profit
Other Income/Expense, Net	$408.0K	$70.00K
YoY Change	482.86%	-65.35%
Pretax Income	-$9.650M	-$2.370M
YoY Change	307.17%	107.89%
Income Tax	-$1.600M	-$30.00K
% Of Pretax Income
Net Earnings	-$8.041M	-$2.340M
YoY Change	243.63%	72.19%
Net Earnings / Revenue	-41.73%	-12.41%
Basic Earnings Per Share
Diluted Earnings Per Share	-$201.1K	-$60.81K
COMMON SHARES
Basic Shares Outstanding	40.19M shares	38.48M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q2	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.000M	$10.80M
YoY Change	-16.67%	-48.82%
Cash & Equivalents	$8.968M	$10.81M
Short-Term Investments
Other Short-Term Assets	$216.0K	$364.0K
YoY Change	-40.66%	-63.2%
Inventory	$16.00M	$15.30M
Prepaid Expenses	$2.636M	$2.835M
Receivables	$16.20M	$11.00M
Other Receivables	$1.200M	$1.600M
Total Short-Term Assets	$46.20M	$43.00M
YoY Change	7.44%	-15.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.00M	$9.900M
YoY Change	11.11%	12.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.200M	$1.300M
YoY Change	69.23%	0.0%
Total Long-Term Assets	$15.70M	$13.80M
YoY Change	13.77%	4.55%
TOTAL ASSETS
Total Short-Term Assets	$46.20M	$43.00M
Total Long-Term Assets	$15.70M	$13.80M
Total Assets	$61.90M	$56.80M
YoY Change	8.98%	-11.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.900M	$4.900M
YoY Change	40.82%	-20.97%
Accrued Expenses	$4.200M	$3.700M
YoY Change	13.51%	-24.49%
Deferred Revenue
YoY Change
Short-Term Debt	$4.500M	$4.200M
YoY Change	7.14%	-12.5%
Long-Term Debt Due	$400.0K	$300.0K
YoY Change	33.33%	0.0%
Total Short-Term Liabilities	$18.00M	$15.00M
YoY Change	20.0%	-18.03%
LONG-TERM LIABILITIES
Long-Term Debt	$100.0K	$400.0K
YoY Change	-75.0%	300.0%
Other Long-Term Liabilities	$4.300M	$3.200M
YoY Change	34.38%	10.34%
Total Long-Term Liabilities	$4.400M	$3.600M
YoY Change	22.22%	20.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.00M	$15.00M
Total Long-Term Liabilities	$4.400M	$3.600M
Total Liabilities	$23.55M	$20.50M
YoY Change	14.87%	-11.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$155.0M
YoY Change
Common Stock	$194.4M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$38.33M	$36.30M
YoY Change
Total Liabilities & Shareholders Equity	$61.88M	$56.80M
YoY Change	8.94%	-11.66%

Cashflow Statement

Concept	2016 Q2	2015 Q2
OPERATING ACTIVITIES
Net Income	-$8.041M	-$2.340M
YoY Change	243.63%	72.19%
Depreciation, Depletion And Amortization	$591.0K	$497.0K
YoY Change	18.91%	9.71%
Cash From Operating Activities	-$2.980M	-$2.210M
YoY Change	34.84%	-14.67%
INVESTING ACTIVITIES
Capital Expenditures	$1.006M	$328.0K
YoY Change	206.71%	-76.8%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities	-$1.010M	-$330.0K
YoY Change	206.06%	-76.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-700.0K	310.0K
YoY Change	-325.81%	-85.51%
NET CHANGE
Cash From Operating Activities	-2.980M	-2.210M
Cash From Investing Activities	-1.010M	-330.0K
Cash From Financing Activities	-700.0K	310.0K
Net Change In Cash	-4.690M	-2.230M
YoY Change	110.31%	19.89%
FREE CASH FLOW
Cash From Operating Activities	-$2.980M	-$2.210M
Capital Expenditures	$1.006M	$328.0K
Free Cash Flow	-$3.986M	-$2.538M
YoY Change	57.05%	-36.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	399000	USD
CY2016Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	187007000	USD
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1580000	USD
CY2016Q1	us-gaap	Liabilities Liabilities	24108000	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-146980000	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	38846000	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	62954000	USD
CY2016Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	76000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-696000	USD
CY2015Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	25000	USD
CY2016Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	247000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13013000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10809000	USD
CY2016Q1	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	3886000	USD
CY2016Q2	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	4064000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-155021000	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	402000	USD
CY2016Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	194010000	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1060000	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	38331000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	61880000	USD
CY2016Q2	us-gaap	Liabilities Liabilities	23549000	USD
CY2016Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	87000	USD
CY2016Q1	us-gaap	Other Assets Current OtherAssetsCurrent	747000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11341000	USD
CY2016Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	17094000	USD
CY2016Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	7281000	USD
CY2016Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	8611000	USD
CY2016Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	8875000	USD
CY2016Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22590000	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23255000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11533000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10675000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10875000	USD
CY2016Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	1909000	USD
CY2016Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2482000	USD
CY2016Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2114000	USD
CY2016Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	736000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	79000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	732000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	62000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	520000	USD
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2278000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7521000	USD
CY2015Q2	us-gaap	Depreciation Depreciation	497000	USD
CY2016Q2	us-gaap	Depreciation Depreciation	591000	USD
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	52000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	54000	USD
CY2015Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-118000	USD
CY2016Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1639000	USD
CY2015Q2	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	50000	USD
CY2016Q2	us-gaap	Increase Decrease In Pension Plan Obligations IncreaseDecreaseInPensionPlanObligations	118000	USD
CY2015Q2	us-gaap	Share Based Compensation ShareBasedCompensation	994000	USD
CY2016Q2	us-gaap	Share Based Compensation ShareBasedCompensation	7458000	USD
CY2015Q2	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	1000	USD
CY2016Q2	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	0	USD
CY2015Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	99000	USD
CY2016Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-22000	USD
CY2015Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	56000	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	317000	USD
CY2015Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-617000	USD
CY2016Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-564000	USD
CY2015Q2	staa	Increase Decrease In Prepaid Expenses Deposits And Other Assets Current IncreaseDecreaseInPrepaidExpensesDepositsAndOtherAssetsCurrent	573000	USD
CY2016Q2	staa	Increase Decrease In Prepaid Expenses Deposits And Other Assets Current IncreaseDecreaseInPrepaidExpensesDepositsAndOtherAssetsCurrent	912000	USD
CY2015Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1741000	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-435000	USD
CY2015Q2	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	309000	USD
CY2016Q2	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-398000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2209000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2979000	USD
CY2015Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	328000	USD
CY2016Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1006000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-326000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1006000	USD
CY2015Q2	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	115000	USD
CY2016Q2	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	92000	USD
CY2015Q2	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	421000	USD
CY2016Q2	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	7000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	306000	USD
CY2016Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3449000	USD
CY2016Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3579000	USD
CY2016Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2636000	USD
CY2016Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1386000	USD
CY2016Q1	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	724000	USD
CY2016Q2	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	620000	USD
CY2016Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2015Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4434000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2204000	USD
CY2016Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	2317000	USD
CY2016Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	2190000	USD
CY2016Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1995000	USD
CY2016Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	2292000	USD
CY2016Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	15058000	USD
CY2016Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	15116000	USD
CY2016Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	182000	USD
CY2016Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	182000	USD
CY2016Q2	us-gaap	Other Assets Current OtherAssetsCurrent	216000	USD
CY2016Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	597000	USD
CY2016Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	597000	USD
CY2016Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	18081000	USD
CY2016Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	6980000	USD
CY2016Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	217000	USD
CY2016Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	28000	USD
CY2016Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	314000	USD
CY2016Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	162000	USD
CY2016Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	540000	USD
CY2016Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	707000	USD
CY2016Q1	us-gaap	Customer Advances And Deposits Current CustomerAdvancesAndDepositsCurrent	203000	USD
CY2016Q2	us-gaap	Customer Advances And Deposits Current CustomerAdvancesAndDepositsCurrent	267000	USD
CY2016Q2	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	139000	USD
CY2016Q1	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	133000	USD
CY2016Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1434000	USD
CY2016Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	875000	USD
CY2015Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	38638000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	39983000	shares
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2016Q2	staa	Incremental Common Shares Attributable To Dilutive Effect Of Nonvested Restricted Stock IncrementalCommonSharesAttributableToDilutiveEffectOfNonvestedRestrictedStock	0	shares
CY2015Q2	staa	Incremental Common Shares Attributable To Dilutive Effect Of Nonvested Restricted Stock IncrementalCommonSharesAttributableToDilutiveEffectOfNonvestedRestrictedStock	-157000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39983000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	38481000	shares
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1740000	shares
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2846000	shares
CY2016Q2	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	60	pure
CY2016Q2	staa	Sales Exceed Percentage SalesExceedPercentage	0.05	pure
CY2016Q2	dei	Document Type DocumentType	10-Q
CY2016Q2	dei	Amendment Flag AmendmentFlag	false
CY2016Q2	dei	Document Period End Date DocumentPeriodEndDate	2016-04-01
CY2016Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2016Q2	dei	Entity Registrant Name EntityRegistrantName	STAAR SURGICAL CO
CY2016Q2	dei	Entity Central Index Key EntityCentralIndexKey	0000718937
CY2016Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-30
CY2016Q2	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2016Q2	dei	Trading Symbol TradingSymbol	STAA
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40186856	shares
CY2016Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1877000	USD
CY2016Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1877000	USD
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40169000	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40169000	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39887000	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39887000	shares
CY2016Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets Period Increase Decrease DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease	-11000	USD
CY2015Q2	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets Period Increase Decrease DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease	-8000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax	-27000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax	-15000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	228000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	24000	USD
CY2016Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	611000	USD
CY2015Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2016Q2	us-gaap	Inventory Gross InventoryGross	19598000	USD
CY2016Q1	us-gaap	Inventory Gross InventoryGross	19370000	USD
CY2016Q2	us-gaap	Defined Benefit Plan Current Assets DefinedBenefitPlanCurrentAssets	307000	USD
CY2016Q1	us-gaap	Defined Benefit Plan Current Assets DefinedBenefitPlanCurrentAssets	0	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	34237000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	32685000	USD
CY2016Q2	staa	Percentage Of Other Current Liabilities PercentageOfOtherCurrentLiabilities	0.05	pure
CY2016Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	151000	USD
CY2015Q2	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	107000	USD
CY2016Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	17000	USD
CY2015Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	19000	USD
CY2016Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	22000	USD
CY2015Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	21000	USD
CY2016Q2	us-gaap	Defined Benefit Plan Amortization Of Net Transition Asset Obligation DefinedBenefitPlanAmortizationOfNetTransitionAssetObligation	3000	USD
CY2015Q2	us-gaap	Defined Benefit Plan Amortization Of Net Transition Asset Obligation DefinedBenefitPlanAmortizationOfNetTransitionAssetObligation	3000	USD
CY2016Q2	staa	Segment Sales To Consolidated Sales Percentage SegmentSalesToConsolidatedSalesPercentage	1	pure
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M25D
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3623000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	486000	shares
CY2016Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	61000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4047000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3674000	shares
CY2016Q2	staa	Estimated Forfeiture Rate EstimatedForfeitureRate	0.09	pure
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	994000	USD
CY2016Q2	staa	Defined Benefit Plan Actuarial Gain Loss Recognized In Current Year DefinedBenefitPlanActuarialGainLossRecognizedInCurrentYear	-24000	USD
CY2015Q2	staa	Defined Benefit Plan Actuarial Gain Loss Recognized In Current Year DefinedBenefitPlanActuarialGainLossRecognizedInCurrentYear	-12000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7458000	USD
CY2016Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	152000	USD
CY2015Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	122000	USD
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	7610000	USD
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	1116000	USD
CY2016Q1	staa	Beneficial Ownership Percentage Of Investor BeneficialOwnershipPercentageOfInvestor	0.26	pure
CY2016Q2	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><i>Prior Year Reclassifications</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 12.95pt; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> During the quarter ended April 1, 2016 the Company reclassified $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">48,000</font> from medical device tax to general and administrative expenses and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">45,000</font> from other income, net to royalty income in the condensed consolidated statement of operations.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q2	us-gaap	Entity Wide Disclosure On Geographic Areas Description Of Revenue From External Customers EntityWideDisclosureOnGeographicAreasDescriptionOfRevenueFromExternalCustomers	The Company markets and sells its products in over 60 countries and does its manufacturing in the United States. Other than Japan, China, United States, Korea, Spain, France and Germany the Company does not conduct business in any country in which its sales exceed 5% of consolidated net sales.

Files In Submission

Name	View Source	Status
0001144204-16-100926-index-headers.html	Edgar Link	pending
0001144204-16-100926-index.html	Edgar Link	pending
0001144204-16-100926.txt	Edgar Link	pending
0001144204-16-100926-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
staa-20160401.xml	Edgar Link	completed
staa-20160401.xsd	Edgar Link	pending
staa-20160401_cal.xml	Edgar Link	unprocessable
staa-20160401_def.xml	Edgar Link	unprocessable
staa-20160401_lab.xml	Edgar Link	unprocessable
staa-20160401_pre.xml	Edgar Link	unprocessable
v438041_10q.htm	Edgar Link	pending
v438041_ex10-35.htm	Edgar Link	pending
v438041_ex31-1.htm	Edgar Link	pending
v438041_ex31-2.htm	Edgar Link	pending
v438041_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STAA
STAAR Surgical Co Stock $staa

2016 Q2 Form 10-Q Financial Statement

#000114420416100926 Filed on May 11, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STAA STAAR Surgical Co Stock $staa

2016 Q2 Form 10-Q Financial Statement

#000114420416100926 Filed on May 11, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STAA
STAAR Surgical Co Stock $staa